Afexa Life Sciences Inc (fka TSX:FXA)

[acobra]

TORONTO, ONTARIO--(Marketwire - Oct. 30, 2009) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA - News) maker of COLD-FX today announced plans to launch a sister product - IMMUNITY-FX - for year round immune health support. The new immune system booster will debut at Toronto's health and lifestyle expo, the "Zoomer Show" Oct 31 - Nov 1.

Related Quotes
Symbol Price Change
FXA.TO 0.90 +0.15


IMMUNITY-FX was designed as a daily immune booster to help consumers stay healthy. It's a special formulation to help the immune system fight germs and pathogens that are foreign to the body. It's the only product of its kind and contains two immune strengthening ingredients - CVT-E002, the active ingredient in COLD-FX which is a clinically proven proprietary extract from the North American ginseng plant, and Reishi mushroom, another natural product recognized world-wide for its effect in strengthening the immune system. Scientific research has uncovered the unique molecular mechanisms of both these ingredients which work together in a complementary manner to stimulate and balance the immune system.

COLD-FX co-discoverer and Afexa Life Sciences Inc. Chief Scientific Officer Dr. Jacqueline Shan says, "IMMUNITY-FX has been in development for a number of years using ChemBioPrint, our proprietary standardization technology which identifies and isolates active ingredients in organic mixtures and ensures consistency and efficacy from batch to batch. IMMUNITY-FX helps strengthen the body's natural defences which are important for improving overall health and wellness and maintaining health when faced with periods of stress. This product is our answer to requests from pharmacists and consumers for a year round daily immune booster."

Dr. Shan adds, "The immune system is a marvellous, complex system. It can recognize and remember millions of different enemies, and it can produce millions of defensive cells to engage in search-and-destroy missions against attacks by foreign invaders. Having a strong immune system is particularly important these days. Our laboratory and clinical research on the core ingredient of IMMUNITY-FX suggests it can enhance the immune system's effectiveness by directly interacting with specific receptor molecules, such as Toll-like receptors, which function as the immune system's 'sentinels' calling for a response when it's under attack. These receptors are critical to the immune function, detecting intruders and triggering protective immune responses."

"We've always been committed to prevention," Dr. Shan continues. "Prevention is better than a cure. The goal should be to enhance the body's own self-defence and self-healing process, to optimize prevention and accelerate recovery. We feel the addition of IMMUNITY-FX to our immune strengthening family of products, which includes COLD-FX, gives consumers added choices for improved health protection and well-being year round."

IMMUNITY-FX is now on the shelves of leading pharmacies, retailers and natural health products stores across Canada. IMMUNITY-FX is the first of two products Afexa plans to roll out during this fiscal year.

About Afexa Life Sciences Inc.

Afexa Life Sciences Inc. (formerly CV Technologies) founded in 1992 strives to transform people's lives to be healthier and happier by focusing on prevention and recovery through the use of evidence-based naturally-derived health products. The Company's lead product COLD-FX® strengthens the immune system and is widely used as a leading over the counter remedy ("OTC") for helping to prevent and relieve cold and flu inflections.